Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss

International Journal of Antimicrobial Agents

Volumn 29, Issue 2, 2007, Pages 201-206

  Lee, Kyungwon ^a   Yong, Dongeun ^a   Choi, Yeong Seon ^a   Yum, Jong Hwa ^a   Kim, June Myung ^a   Woodford, Neil ^b   Livermore, David M ^b   Chong, Yunsop ^a  

^a Yonsei University College of Medicine   (South Korea)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

AmpC; Impermeability; Klebsiella; Outer membrane protein

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; COTRIMOXAZOLE; GENOMIC DNA; GENTAMICIN; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; NETILMICIN; OUTER MEMBRANE PROTEIN; PENICILLIN G; PORIN; TOBRAMYCIN;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONAL VARIATION; CONJUGATION; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE SEQUENCE; GENE TRANSFER; KLEBSIELLA PNEUMONIAE; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMIPENEM; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PORINS;

EID: 33846074974     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.09.006     Document Type: Article

References (15)

1. Podschun R., and Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11 (1998) 589-603
2. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46 (2002) 1-11
3. Lee K., Lee M., Shin J.H., et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 12 (2006) 44-49
4. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 18 (2005) 306-325
5. Martinez-Martinez L., Pascual A., Hernandez-Alles S., et al. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 43 (1999) 1669-1673
6. Farmer III J.J. Enterobacteriaceae: introduction and identification. In: Murray P.A., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of clinical microbiology. 8th ed. (2003), American Society for Microbiology, Washington, DC 336-353
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing (2003), NCCLS, Wayne, PA [Suppl. M100-S13]
8. Lee K., Hong S.G., Park Y.J., et al. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC β-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae. Diagn Microbiol Infect Dis 53 (2005) 319-323
9. Yagi T., Wachino J., Kurokawa H., et al. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 43 (2005) 2551-2558
10. Chart H. Bacterial fractionation and membrane protein characterization. In: Chart H. (Ed). Methods in practical laboratory bacteriology (1994), CRC Press, London, UK 1-10
11. Domenech-Sanchez A., Martinez-Martinez L., Hernandez-Alles S., et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 47 (2003) 3332-3335
12. Bradford P.A., Urban C., Mariano R., Projan S.J., Rahal J.J., and Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41 (1997) 563-569
13. Cao V.T., Arlet G., Ericsson B.M., Tammelin A., Courvalin P., and Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 46 (2000) 895-900
14. Bidet P., Burghoffer B., Gautier V., et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother 49 (2005) 3562-3565
15. Poirel L., Héritier C., Spicq C., and Nordmann P. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 42 (2004) 3831-3833